Sanders Morris Harris’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,100
| Closed | -$646K | – | 192 |
|
|
2025
Q1 | $646K | Hold |
21,100
| – | – | 0.1% | 133 |
|
|
2024
Q4 | $1.08M | Buy |
21,100
+2,500
| +13% | +$128K | 0.16% | 95 |
|
|
2024
Q3 | $950K | Hold |
18,600
| – | – | 0.16% | 97 |
|
|
2024
Q2 | $833K | Hold |
18,600
| – | – | 0.14% | 104 |
|
|
2024
Q1 | $871K | Hold |
18,600
| – | – | 0.16% | 101 |
|
|
2023
Q4 | $663K | Hold |
18,600
| – | – | 0.33% | 88 |
|
|
2023
Q3 | $512K | Hold |
18,600
| – | – | 0.11% | 148 |
|
|
2023
Q2 | $336K | Buy |
+18,600
| New | +$336K | 0.07% | 183 |
|
|
2023
Q1 | – | Sell |
-18,600
| Closed | -$340K | – | 167 |
|
|
2022
Q4 | $340K | Hold |
18,600
| – | – | 0.13% | 143 |
|
|
2022
Q3 | $353K | Hold |
18,600
| – | – | 0.09% | 173 |
|
|
2022
Q2 | $351K | Hold |
18,600
| – | – | 0.08% | 185 |
|
|
2022
Q1 | $408K | Hold |
18,600
| – | – | 0.08% | 190 |
|
|
2021
Q4 | $523K | Hold |
18,600
| – | – | 0.09% | 163 |
|
|
2021
Q3 | $368K | Hold |
18,600
| – | – | 0.07% | 211 |
|
|
2021
Q2 | $388K | Hold |
18,600
| – | – | 0.08% | 212 |
|
|
2021
Q1 | $306K | Hold |
18,600
| – | – | 0.06% | 225 |
|
|
2020
Q4 | $263K | Hold |
18,600
| – | – | 0.06% | 227 |
|
|
2020
Q3 | $311K | Buy |
+18,600
| New | +$311K | 0.08% | 200 |
|